Source: International Congress 2018 – Role of IgE and interleukin (IL)-5 in Th2-cell signatures
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
I. Kuprys-Lipinska (Lodz, Poland), L. Mastalerz (Cracow, Poland), P. Majak (Lodz, Poland), K. Tyrak (Cracow, Poland), J. Molinska (Lodz, Poland), M. Jonakowski (Lodz, Poland), Z. Kurmanowska (Lodz, Poland), M. Latek (Lodz, Poland), D. Krzyzanowski (Lodz, Poland), A. Zal (Lodz, Poland), P. Kuna (Lodz, Poland). The effect of omalizumab on blood eosinophils count in patients with hypersensitivity to non-steroidal anti-inflammatory drugs (NSAID) compare to patients who tolerate NSAID–pilot study. 1128

Member's Comments

No comment yet.

Related content which might interest you: A randomized trial of AZD7594 a novel non-steroidal anti-inflammatory drug in asthma patients Source: International Congress 2017 – Novel mechanisms and treatments for asthma Year: 2017 Inhalations of ultra-low doses of alkylating drug for the treatment of steroid-dependant asthma: anti-inflammatory effect of therapy Source: Eur Respir J 2001; 18: Suppl. 33, 266s Year: 2001 Efficacy of low dose theophylline in patient with bronchial asthma - anti-inflammatory effect Source: Eur Respir J 2003; 22: Suppl. 45, 102s Year: 2003 Pharmacogenetics of anti-inflammatory treatment in children with asthma Source: Annual Congress 2013 –Towards personalised medicine in respiratory diseases in children Year: 2013 Antitussive and antiinflammatory effect of montelukast in patients with cough variant asthma Source: Eur Respir J 2006; 28: Suppl. 50, 440s Year: 2006 Efficacy and safety of BI 671800, an oral CRTH2 antagonist, as add on therapy in poorly controlled asthma patients prescribed an inhaled corticosteroid Source: Annual Congress 2012 - New bronchodilators and other novel drugs for asthma and COPD Year: 2012 Efficacy and safety of BI 671800, an oral CRTH2 antagonist, as add on therapy in poorly controlled asthma patients prescribed an inhaled corticosteroid Source: Annual Congress 2012 - Trials in asthma: asthma exacerbations and severe asthma Year: 2012 The cost-efficacy of combined anti-inflammatory therapy in the treatment of children in severe persistent asthma Source: Eur Respir J 2003; 22: Suppl. 45, 134s Year: 2003 Fluticasone furoate (FF), a once-daily inhaled corticosteroid (ICS), demonstrates dose-response efficacy in patients symptomatic on non-steroidal asthma therapy Source: Annual Congress 2010 - New treatments for asthma and COPD Year: 2010 Formoterol enhances anti-inflammatory effects of corticosteroid in peripheral blood mononuclear cells from COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 215s Year: 2006 Tralokinumab did not demonstrate oral corticosteroid-sparing effects in severe asthma Source: Eur Respir J, 53 (2) 1800948; 10.1183/13993003.00948-2018 Year: 2019 Association between blood eosinophil count and exacerbation risk in patients with asthma receiving medium- or high-dosage inhaled corticosteroids Source: International Congress 2017 – Biomarker-based asthma control Year: 2017 Azithromycin in the anti-inflammatory treatment of children with asthma Source: Eur Respir J 2004; 24: Suppl. 48, 167s Year: 2004 Immunomodulatory treatment of severe persistent asthma with interferon-αcon-1 (IFN-αcon-1). Effect on the clinical course of oral corticosteroid dose and eosinophil numbers Source: Annual Congress 2003 - Modulation of bronchial hyperreactivity and immune response in the airways Year: 2003 Clinical and biochemical differences between patients with aspirin-induced asthma/rhinitis Source: Annual Congress 2005 - PG18 - Inter-relationships between upper and lower airway diseases Year: 2005 Long-term efficacy of 1 year anti-inflammatory treatment in paediatric patients with mild persistent asthma Source: Eur Respir J 2004; 24: Suppl. 48, 379s Year: 2004 Oral corticosteroid (OCS)-sparing effect of tralokinumab in severe, uncontrolled asthma: the TROPOS study Source: International Congress 2018 – Innovative therapies in asthma and COPD Year: 2018 Anti-asthmatic drugs: treatment of athletes and exercise-induced bronchoconstriction Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-22-7, page=73 Year: 2005 The effect of combined β2-agonist and anticholinergic inhaled therapy in patients with COPD Source: Eur Respir J 2004; 24: Suppl. 48, 341s Year: 2004